PATENT CLAIM ANALYSIS

Application Number: 15779106
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
According to the invention, immunogenicity of an antigenic peptide is increased by administering a fusion protein, which comprises an antigenic peptide and an adjuvant protein, wherein the adjuvant protein comprises two or more proteins selected from the group consisting of a Shiga toxin 2e B subunit (Stx2eB), an  Escherichia coli  heat-labile toxin B subunit (LTB), and a cholera toxin B subunit (CTB). or a transformant transformed by a gene coding for the fusion protein.

Claim (Index 19):
A vaccine, comprising:\n the fusion protein according to  claim 1  or a transformant transformed with a recombinant vector comprising a DNA construct comprising a DNA coding for the fusion protein.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.74
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12990597', '15039697', '12667393', '10565595', '12083031']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7542384116818505
- 35 USC 102 Novelty (BERT): 0.5376664800328237
- Combined Prediction Score: 0.7325812185169478
- Mean Citation Score: 341.521018
- Max Citation Score: 382.4544
- Similarity Product: 286.97429371948243

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test